Gf Fund Management Co. Ltd. Tarsus Pharmaceuticals, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $5.51 Trillion
- Q3 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 908 shares of TARS stock, worth $65,557. This represents 0.0% of its overall portfolio holdings.
Number of Shares
908
Previous 978
7.16%
Holding current value
$65,557
Previous $39.6 Million
36.2%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TARS
# of Institutions
231Shares Held
45MCall Options Held
51.6KPut Options Held
15.8K-
Black Rock Inc. New York, NY3.27MShares$236 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.18MShares$229 Million2.52% of portfolio
-
Deep Track Capital, LP Greenwich, CT3MShares$217 Million5.63% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.67MShares$192 Million5.1% of portfolio
-
Jennison Associates LLC2.6MShares$188 Million0.09% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.92B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...